Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 2 |
2019 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin.
Nat Commun. 2016 May 16;7:11581. doi: 10.1038/ncomms11581.
Nat Commun. 2016.
PMID: 27181366
Free PMC article.
Cyclin D1 (Ccnd1) together with its binding partner Cdk4 act as a transcriptional regulator to control cell proliferation and migration, and abnormal Ccnd1.Cdk4 expression promotes tumour growth and metastasis. ...Here, we show that the focal ad …
Cyclin D1 (Ccnd1) together with its binding partner Cdk4 act as a transcriptional regulator to control cell …
Cyclin D1 promotes tumor cell invasion and metastasis by cytoplasmic mechanisms.
Fusté NP, Ferrezuelo F, Garí E.
Fusté NP, et al.
Mol Cell Oncol. 2016 Jun 27;3(5):e1203471. doi: 10.1080/23723556.2016.1203471. eCollection 2016.
Mol Cell Oncol. 2016.
PMID: 27857971
Free PMC article.
Amplification of cyclin D1 is a frequent alteration in many cancers of different type and origin. We recently described a novel regulatory axis involving cyclin D1 in the regulation of tumor invasion and metastasis. Membrane …
Amplification of cyclin D1 is a frequent alteration in many cancers of different type and origin. We recently described a nove …
Item in Clipboard
Progesterone Receptor B signaling Reduces Breast Cancer Cell Aggressiveness: Role of Cyclin-D1/Cdk4 Mediating Paxillin Phosphorylation.
Montalto FI, Giordano F, Chiodo C, Marsico S, Mauro L, Sisci D, Aquila S, Lanzino M, Panno ML, Andò S, De Amicis F.
Montalto FI, et al.
Cancers (Basel). 2019 Aug 17;11(8):1201. doi: 10.3390/cancers11081201.
Cancers (Basel). 2019.
PMID: 31426542
Free PMC article.
Progesterone-Receptor (PR) positivity is related with an enhanced response to breast cancer therapy, conversely cyclin D1 (CD1) is a retained marker of poor outcome. Herein, we demonstrate that hydroxyprogesterone (OHPg) through progesterone receptor B (PR-B) reduce …
Progesterone-Receptor (PR) positivity is related with an enhanced response to breast cancer therapy, conversely cyclin D1 (CD1 …
Item in Clipboard
Cite
Cite